The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Services
  • Entertainment
  • Construction
  • Sports

Roger B. Bagwell, Ph.D., is named the Actuated Medical Director, Neural Device Operations
The PennZone/10296264

Trending...
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 221
  • Rio Bela Cosmetics Launches Inclusive Line of Organic Skincare Products
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
Actuated Medical Inc.
BELLEFONTE, Pa. - PennZone -- Actuated Medical, Inc. is pleased to announce that Roger B. Bagwell, Ph.D. is now the Actuated Medical Director, Neural Device Operations. This transition reflects the company's continued expansion in the neural device sector and Dr. Bagwell's pivotal role in advancing Actuated's cutting-edge technologies.

As Director, Neural Device Operations, Dr. Bagwell will oversee the development, optimization, and strategic direction of Actuated's neural-focused device portfolio, Actuated Neuroscience, ensuring performance excellence from concept to commercialization. He will lead engagement with brain researchers and brain computer interface (BCI) companies that are focused on improving outcomes for patients dealing with neurological conditions.

"Our team has made significant strides in helping the neural device researcher achieve better data to improve their understanding of the brain. With Roger at the helm of our neural device operations, we are confident that we will continue delivering groundbreaking solutions to enable clinical researchers to improve patient outcomes." said Maureen L. Mulvihill, Ph.D., President and CEO of Actuated Medical.

More on The PennZone
  • America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience

"I am excited to take this step and transition my position to Director, Neural Device Operations. Actuated Neuroscience has an immense amount of neural technology ideas, and I look forward to leading our talented team in developing advanced solutions that enhance patient care and expand the possibilities of neural device applications." said Roger B. Bagwell, Ph.D.

Actuated Medical is committed to pushing the boundaries of medical technology through innovation and collaboration. This transition underscores the company's dedication to developing advanced solutions that extend the longevity and performance of penetrating neural implants and other neuro-focused medical devices.

About Actuated Medical, Inc.

Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 43 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified ISO 13485 and a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com

More on The PennZone
  • Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
  • Signature Smiles Dental Group Unveils New User-Friendly Website
  • CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
  • QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
  • Local Holistic Consultant Pharmacist Featured on National Podcast as FDA Updates Hormone Therapy Safety

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

ActuatedMedical.com

GripTract.com

ActuatedNeuroscience.com

TubeClear.com

Contact
Actuated Medical, Inc.
***@actuatedmedical.com


Source: Actuated Medical, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • NEW SEASON OF "The Really Real Estate" APPROVED
  • UK Financial Ltd Announces Full Ecosystem To Erc-3643 "SEC-Ready" Tokens For All UK Financial Ltd Tokenized Projects
  • Pushing the Wave Series Launches Premium Hardback Editions of 2017–2022 and 2023 Volumes
  • ZEELOOL 2025 Black Friday and Cyber Monday Big Deals
  • Americans Are Building Family Legacies That Last Generations — Not Just Paychecks That Last a Month
  • Bent Danholm Lists Contemporary Lakefront Residence in Winter Garden's Avalon Cove
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
  • NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
  • Rio Bela Cosmetics Launches Inclusive Line of Organic Skincare Products
  • The 7 Visibility Problems Costing Independent Hotels Thousands Every Month
  • Viola's Babygirl's, LLC Proudly Announces Teri Tobin's Soulful New Christmas EP "Home For The Holidays"
  • Stoxtel Introduces High-Throughput "Matrix" Engine to Address Mexico's Crypto Trading Volatility
  • Eagles LB Jihaad Campbell Brings Surprise Visit for Together We Dance Foundation
  • UK Financial Ltd Sets Listing Date With Catex Exchange For The Listing Of Mayacat The World's First Ever Gold Backed ERC 3643 "SEC Ready" Token
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • Althea Gibson Honored as Final Release in U.S. Mint's American Women Quarters Program
  • ToneWell Launches AI Wellness Platform with 30-Second Voice-Based Performance Readiness Scan™
  • Lokal Media House Achieves Yelp Platinum Partner Status
  • World's First AI-Native Industrial Facility is Under Construction by Carbon AMS with rhobot.ai

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 221
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 139
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
  • Revenue Optics Ignites AI Revolution in Industrial Distribution
  • Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia
  • HR Soul Consulting Recognized as a 2025 Inc. Power Partner Award Winner for the Fourth Consecutive Year
  • Passion Struck Network Debuts: A Creator-First Platform for Purpose-Driven Podcasting and Human Impact
  • The Quirky Charm Of Unconventional Storytelling

Similar on PennZone

  • Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
  • Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
  • Signature Smiles Dental Group Unveils New User-Friendly Website
  • CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
  • Local Holistic Consultant Pharmacist Featured on National Podcast as FDA Updates Hormone Therapy Safety
  • The Patina Collective & Artist Jesse Draxler Debut "The Machine of Loving Grace"
  • Star Sleep & Wellness Expands to Pearland, Texas — Bringing Life-Changing Sleep Care to More Communities
  • Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us